Literature DB >> 11124910

Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.

J Gu1, R A Villanueva, C S Snyder, M J Roth, M M Georgiadis.   

Abstract

Reverse transcriptase, an essential retroviral DNA polymerase, replicates the single-stranded RNA genome of the retrovirus, producing a double-stranded DNA copy, which is subsequently integrated into the host's genome. Substitution of Ala for either Asp114 or Arg116, two highly conserved residues in the fingers domain of Moloney murine leukemia virus reverse transcriptase, results in enzymes (D114A or R116A) with significant defects in their abilities to processively synthesize DNA using RNA or DNA as a template. D114A and R116A enzymes also bind more weakly to template-primer in the presence of added deoxyribonucleotides, as seen by gel-shift analysis, but retain the ability to strand transfer and accumulate smaller RNase H cleavage products when compared to the wild-type enzyme. In addition, mutant proviruses, including D114A and R116A substitutions in Moloney murine leukemia virus reverse transcriptase, are not viable despite the presence of processed reverse transcriptase in the viral particles. A potential mechanistic role in processive synthesis for D114 and R116 is discussed in the context of our results, related studies on HIV-1 reverse transcriptase, and previous structural studies. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124910     DOI: 10.1006/jmbi.2000.4281

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.

Authors:  D Das; M M Georgiadis
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

2.  Engineered CRISPR prime editors with compact, untethered reverse transcriptases.

Authors:  Julian Grünewald; Bret R Miller; Regan N Szalay; Peter K Cabeceiras; Christopher J Woodilla; Eliza Jane B Holtz; Karl Petri; J Keith Joung
Journal:  Nat Biotechnol       Date:  2022-09-26       Impact factor: 68.164

Review 3.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

Review 4.  M-MuLV reverse transcriptase: Selected properties and improved mutants.

Authors:  Igor P Oscorbin; Maxim L Filipenko
Journal:  Comput Struct Biotechnol J       Date:  2021-11-22       Impact factor: 7.271

5.  Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid.

Authors:  Elzbieta Nowak; Wojciech Potrzebowski; Petr V Konarev; Jason W Rausch; Marion K Bona; Dmitri I Svergun; Janusz M Bujnicki; Stuart F J Le Grice; Marcin Nowotny
Journal:  Nucleic Acids Res       Date:  2013-02-04       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.